Mon to Sun 9:00 am to 12:00 am

Karachi, Pakistan

ASCO: Akeso’s ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34% - Fierce Pharma

ASCO: Akeso’s ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34% - Fierce Pharma

By Angus Liu | Published: May 31, 2026

No additional content available.

Read Full Article
whatsapp
SCROLL TO TOP